Product NDC: | 0173-0741 |
Proprietary Name: | CEFTIN |
Non Proprietary Name: | cefuroxime axetil |
Active Ingredient(s): | 250 mg/5mL & nbsp; cefuroxime axetil |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0741 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050672 |
Marketing Category: | NDA |
Start Marketing Date: | 20040602 |
Package NDC: | 0173-0741-10 |
Package Description: | 50 mL in 1 BOTTLE, GLASS (0173-0741-10) |
NDC Code | 0173-0741-10 |
Proprietary Name | CEFTIN |
Package Description | 50 mL in 1 BOTTLE, GLASS (0173-0741-10) |
Product NDC | 0173-0741 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefuroxime axetil |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20040602 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | CEFUROXIME AXETIL |
Strength Number | 250 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |